Renaissance Capital logo

Elanco Animal Health Priced, NYSE: ELAN

Spin-off of Eli Lilly's global animal health medicines and vaccines business.

Industry: Health Care

First Day Return: +50.0%

Industry: Health Care

Founded in 1954 as part of Eli Lilly and Company, Elanco is a premier animal health company that innovates, develops, manufactures and markets products for companion and food animals. Headquartered in Greenfield, Indiana, we are the fourth largest animal health company in the world, with revenue of $2.9 billion for the year ended December 31, 2017. Globally, we are #1 in medicinal feed additives, #2 in poultry and #3 in cattle, measured by 2017 revenue, according to Vetnosis. We also have one of the broadest portfolios of pet parasiticides in the companion animal sector. We offer a diverse portfolio of more than 125 brands that make us a trusted partner to veterinarians and food animal producers in more than 90 countries.
more less
IPO Data
IPO File Date 08/02/2018
Offer Price $24.00
Price Range $20.00 - $23.00
Offer Shares (mm) 62.9
Deal Size ($mm) $1,510
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 09/19/2018
Offer Price IPO Intelligence Only
Price Range IPO Intelligence Only
Offer Shares (mm) IPO Intelligence Only
Deal Size ($mm) $1,510
Lock-Up Date IPO Intelligence Only
Street Research IPO Intelligence Only
Underwriters
IPO Intelligence Only
Company Data
Headquarters Greenfield, IN, United States
Founded 1954
Employees at IPO 5,880
Website www.elanco.com

Elanco Animal Health (ELAN) Performance